Medicines to Africa: CAMR doesn’t need ‘fixing’
Here is the heartening truth: much-needed medications will flow at little or no price to Africa regardless of whether politicians try to revise CAMR. If MPs pass proposed legislation to amend CAMR, they will render it unworkable.
In 2007, GlaxoSmithKline Inc. (GSK), the research-based pharmaceutical organization which I am proud to lead, participated with Apotex to manufacture and ship HIV/AIDS medication to Rwanda under Canada's Access to Medicines Regime (CAMR). Unfortunately, in the six years since CAMR was introduced...
SPONSORED CONTENT
Get Today’s Headlines Newsletter
Your quick scan of the news you need each weekday to be the smartest person in the room.
By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy
